-
Mashup Score: 1
This study proposes inhibition of cyclin-dependent kinases as a clinically translatable combinatorial strategy to enhance the efficacy of oncolytic virotherapy in GBM.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 7
Researchers at Mayo Clinic’s Center for Individualized Medicine have devised an immunotherapy technique that combines chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, with a cancer-killing virus to more effectively target and treat solid cancer tumors.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0TG6002, an oncolytic virus induces expression of a pro-drug activating enzyme in advanced GI cancers - 3 year(s) ago
Kaidre Bendjama, Transgene, Strasborg, France, presents the findings of an ongoing Phase I study evaluating oral flucytosine (5-FC) in combination…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Using oncolytic viruses in solid tumors - 3 year(s) ago
Kaidre Bendjama, Transgene, Strasborg, France, considers the potential of oncolytic viruses such as TG6002 in the management of gastrointestinal malignancies,…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 27Oncolytic Virus Kills Tumor Cells and Supports Immune Cells - 4 year(s) ago
Researchers have engineered an oncolytic virus to kill cancer cells and improve the body’s immune response against tumors. The virus attacks cancer cells and provides immune cells drawn into tumors with a hormone they need to perform their own cell-killing functions.
Source: National Cancer InstituteCategories: Hem/Onc News and JournalsTweet
High-throughput screening identifies inhibition of cyclin-dependent kinases as a clinically translatable combinatorial strategy to enhance the efficacy of #oncolyticvirus treatment in glioblastoma, by Xiao. https://t.co/VPeXujwRsD @Centre2i https://t.co/CeIM5rfolD